文献
J-GLOBAL ID:201902271454111165
整理番号:19A0079814
EGFR変異体肺癌におけるEGFR阻害剤耐性の不均一機構に対する治療戦略としてのターゲティングδδ【JST・京大機械翻訳】
Targeting PKCδ as a Therapeutic Strategy against Heterogeneous Mechanisms of EGFR Inhibitor Resistance in EGFR-Mutant Lung Cancer
著者 (59件):
Lee Pei-Chih
(Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA)
,
Fang Yueh-Fu
(Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA)
,
Fang Yueh-Fu
(Department of Thoracic Medicine, Chang Gung Foundation, Chang Gung Memorial Hospital, Taoyuan 333, Taiwan)
,
Fang Yueh-Fu
(Department of Pulmonary and Critical Care Medicine Saint Paul’s Hospital, Taoyuan City 33069, Taiwan)
,
Fang Yueh-Fu
(College of Medicine, Chang Gung University, Taoyuan 333, Taiwan)
,
Yamaguchi Hirohito
(Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA)
,
Wang Wei-Jan
(Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA)
,
Chen Tse-Ching
(College of Medicine, Chang Gung University, Taoyuan 333, Taiwan)
,
Chen Tse-Ching
(Department of Pathology, Chang Gung Foundation, Chang Gung Memorial Hospital, Taoyuan 333, Taiwan)
,
Hong Xuan
(Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA)
,
Hong Xuan
(Thoracic Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150081, China)
,
Ke Baozhen
(Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA)
,
Xia Weiya
(Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA)
,
Wei Yongkun
(Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA)
,
Zha Zhengyu
(Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA)
,
Wang Yan
(Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA)
,
Kuo Han-Pin
(Department of Thoracic Medicine, Chang Gung Foundation, Chang Gung Memorial Hospital, Taoyuan 333, Taiwan)
,
Kuo Han-Pin
(College of Medicine, Chang Gung University, Taoyuan 333, Taiwan)
,
Wang Chih-Wei
(College of Medicine, Chang Gung University, Taoyuan 333, Taiwan)
,
Wang Chih-Wei
(Department of Pathology, Chang Gung Foundation, Chang Gung Memorial Hospital, Taoyuan 333, Taiwan)
,
Tu Chih-Yen
(Division of Pulmonary and Critical Care Medicine, China Medical University and Hospital, Taichung 404, Taiwan)
,
Tu Chih-Yen
(Department of Internal Medicine, China Medical University and Hospital, Taichung 404, Taiwan)
,
Tu Chih-Yen
(School of Medicine, China Medical University, Taichung 404, Taiwan)
,
Tu Chih-Yen
(Department of Life Science, National Chung-Hsing University, Taichung 402, Taiwan)
,
Chen Chia-Hung
(Division of Pulmonary and Critical Care Medicine, China Medical University and Hospital, Taichung 404, Taiwan)
,
Chen Chia-Hung
(Department of Internal Medicine, China Medical University and Hospital, Taichung 404, Taiwan)
,
Chen Chia-Hung
(Department of Respiratory Therapy, China Medical University, Taichung 404, Taiwan)
,
Chen Chia-Hung
(Graduate Institute of Clinical Medical Science, China Medical University, Taichung 404, Taiwan)
,
Huang Wei-Chien
(Center for Molecular Medicine and Graduate Institute of Biomedical Sciences, China Medical University, Taichung 404, Taiwan)
,
Huang Wei-Chien
(Department of Biotechnology, Asia University, Taichung 413, Taiwan)
,
Chiang Shu-Fen
(Cancer Center, China Medical University, Taichung 404, Taiwan)
,
Nie Lei
(Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA)
,
Hou Junwei
(Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA)
,
Chen Chun-Te
(Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA)
,
Huo Longfei
(Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA)
,
Yang Wen-Hao
(Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA)
,
Deng Rong
(Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA)
,
Deng Rong
(State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-sen University, Guangzhou 510060, China)
,
Nakai Katsuya
(Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA)
,
Hsu Yi-Hsin
(Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA)
,
Chang Shih-Shin
(Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA)
,
Chiu Tai-Jan
(Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA)
,
Chiu Tai-Jan
(Department of Medical Oncology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung 333, Taiwan)
,
Tang Jun
(Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA)
,
Tang Jun
(State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-sen University, Guangzhou 510060, China)
,
Zhang Ran
(Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA)
,
Wang Li
(Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA)
,
Fang Bingliang
(Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA)
,
Chen Ting
(Division of Hematology & Medical Oncology, Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY 10016, USA)
,
Chen Ting
(Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA)
,
Wong Kwok-Kin
(Division of Hematology & Medical Oncology, Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY 10016, USA)
,
Wong Kwok-Kin
(Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA)
,
Wong Kwok-Kin
(Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA 02215, USA)
,
Hsu Jennifer L.
(Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA)
,
Hsu Jennifer L.
(Center for Molecular Medicine and Graduate Institute of Biomedical Sciences, China Medical University, Taichung 404, Taiwan)
,
Hsu Jennifer L.
(Department of Biotechnology, Asia University, Taichung 413, Taiwan)
,
Hung Mien-Chie
(Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA)
,
Hung Mien-Chie
(Center for Molecular Medicine and Graduate Institute of Biomedical Sciences, China Medical University, Taichung 404, Taiwan)
,
Hung Mien-Chie
(Department of Biotechnology, Asia University, Taichung 413, Taiwan)
資料名:
Cancer Cell
(Cancer Cell)
巻:
34
号:
6
ページ:
954-969.e4
発行年:
2018年
JST資料番号:
W1844A
ISSN:
1535-6108
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)